Tim Fox

Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in Non-Small Cell Lung Cancer.

Jacob G. Scott, M. Kattan, S. Eschrich, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Optimizing Clinical Outcome and Toxicity in Lung Cancer Using a Genomic Marker of Radiosensitivity

Jacob G. Scott, M. Kattan, S. Eschrich, 2020 .

Characterization of primary prostate carcinoma by anti-1-amino-2-[18F] -fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC) uptake

B. Fei, C. Moreno, D. Schuster, 2013 .

Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake.

B. Fei, C. Moreno, D. Schuster, 2013, American journal of nuclear medicine and molecular imaging.

Increased expression of Ki-67 correlates with synthetic amino acid PET radiotracer uptake in prostate cancer

B. Fei, D. Schuster, V. Master, 2012 .

Original Article Characterization of primary prostate carcinoma by anti-1-amino-2-( 18 F) -fluorocyclobutane-1-carboxylic acid (anti-3-( 18 F) FACBC) uptake

B. Fei, C. Moreno, D. Schuster, 2013 .